Featured Archives - IPHA
September 14, 2022

Biogen’s Michael O’Connell named as new IPHA President

Biogen’s Michael O’Connell named as new IPHA President Takeda’s Shane Ryan confirmed as Vice-President as industry focuses on a better environment for access, competitiveness and innovation […]
July 4, 2022

Two in five people believe pandemic will never be fully over, says Ipsos survey for IPHA

Two in five people believe pandemic will never be fully over, says Ipsos survey for IPHA Half of people believe Covid-19 pandemic will eventually end while […]
June 20, 2022

Over half the public has favourable opinion about pharmaceutical industry, says Ipsos survey for IPHA

Over half the public has favourable opinion about pharmaceutical industry, says Ipsos survey for IPHA Latest research shows public values science and the industry’s local societal […]
May 11, 2022

Global Covid-19 vaccines equity of access is a ‘shared goal’ as production surges, says industry

Global equity of access to Covid-19 vaccines should be a shared goal, according to the research-based biopharmaceutical industry, with production set to reach 16.3 billion doses by […]
May 9, 2022

Ireland’s spending on medicines is ‘stable’ as patient access challenges persist, says IPHA

Ireland’s spend on medicines as a proportion of overall health expenditure is below the average of 15 other European countries, according an industry analysis of official […]
April 11, 2022

Ireland places 27th out of 35 countries for speed of access to new cancer medicines

Europe-wide survey of EMA-authorised medicines between 2017 and 2020 shows lengthening wait times for Irish patients  Germany is over four times faster than Ireland to make […]
March 21, 2022

Nine in 10 people believe vaccines are effective, according to Ipsos survey for IPHA

91% trust doctors and nurses for accurate information about vaccines Number of ‘vaccine believers’ up 11 points since before the pandemic Almost three in five adults […]
March 4, 2022

Biopharmaceutical industry responds to invasion of Ukraine

Following the invasion of Ukraine, the research-based biopharmaceutical industry is responding through solidarity, supply and support. We condemn the invasion of Ukraine and stands in solidarity […]
December 15, 2021

New medicines supply Agreement to improve patients’ access to innovative new treatments

For immediate release: 15th December, 2021 New medicines supply Agreement to improve patients’ access to innovative new treatments Four-year Agreement reached between international research-based biopharmaceutical industry […]